Skip to content
★ Sign in to follow
JS

James Stambaugh

Executive
Intersect ENT, Inc.
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€1.1M

Latest filing published 07 Sept 2016 for Intersect ENT, Inc., €4,285.

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

James Stambaugh: trading record in brief

James Stambaugh appears in our data through filings on Intersect ENT, Inc. shares, published by SEC (Form 4). The record holds 15 filings, for trades running from 2 February 2015 to 6 September 2016.

On the market, this insider has only sold: 10 sales, €1.1M in total. Outside the open market, there are 5 option exercises. In 2016 alone, the filings show no purchases and 5 sales.

The newest entry dates from 7 September 2016: an open-market sale of €4,285, in Intersect ENT, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to James Stambaugh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations